Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands-Reference-Cited by-同舟云学术

Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands

Published:2018-05-09 Issue:9 Volume:57 Page:1185-1191
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Zijlstra Myrte¹²,van der Geest Lydia G. M.¹,van Laarhoven Hanneke W. M.³,Lemmens Valery E. P. P.¹⁴,van de Poll-Franse Lonneke V.¹⁵⁶,Raijmakers Natasja J. H.¹

Affiliation:

1. Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands;

2. Department of Medical Oncology, Radboud MC, Nijmegen, The Netherlands;

3. Department of Medical Oncology, Academic MC, Amsterdam, The Netherlands;

4. Department of Public Health, Erasmus MC, Rotterdam, The Netherlands;

5. CoRPS – Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands;

6. Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2018.1470330

Reference42 articles.

1. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

2. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

3. nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of MR-Guided Radiation Therapy for Pancreatic Cancer;Seminars in Radiation Oncology;2024-01

2. Timing of Initiation of Palliative Chemotherapy in Asymptomatic Patients with Metastatic Pancreatic Cancer: An International Expert Survey and Case-Vignette Study;Cancers;2023-11-27

3. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design;BMC Cancer;2022-12-29

4. Are older patients less likely to be treated for pancreatic cancer? A systematic review and meta-analysis;Cancer Epidemiology;2022-10

5. The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK;Journal of Gastrointestinal Surgery;2021-09-10